Research Site
Saint Joseph, Michigan 49085
2 studies enrolling now · 13 studies all time
What they study most
Acute Coronary Syndrome, Breast Cancer, Carcinoma, Chronic Kidney Disease and Hypertension, Chronic Lymphocytic Leukemia, Colon Cancer, Colorectal Cancer, Cost Sharing, Acute Coronary Syndrome, Elevated High-sensitivity C-Reactive Protein (hsCRP), Locally Advanced Breast Cancer, Metastases, Metastatic Breast Cancer
Studies at this site
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin — Recruiting now
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Recruiting now
- A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease — Recruiting now
- Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer — Running, not enrolling
- A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. — Running, not enrolling
- Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
- Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study — Completed
- Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) — Stopped early
- The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer — Completed
- Phase 1b/2 Study of AMG 655 With mFOLFOX6 and Bevacizumab for First-Line Metastatic Colorectal Cancer — Completed
- JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events — Stopped early
- Iressa Expanded Access Program (EAP) — Completed
- Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma — Stopped early